WBI Investments LLC Has $602,000 Stock Position in Cencora, Inc. $COR

WBI Investments LLC cut its holdings in shares of Cencora, Inc. (NYSE:COR) by 49.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,927 shares of the company’s stock after selling 1,899 shares during the quarter. WBI Investments LLC’s holdings in Cencora were worth $602,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. United Bank grew its position in Cencora by 4.5% during the second quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares in the last quarter. Dorsey & Whitney Trust CO LLC boosted its position in Cencora by 3.7% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 1,596 shares of the company’s stock valued at $479,000 after purchasing an additional 57 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its stake in Cencora by 16.3% in the second quarter. Pinnacle Wealth Planning Services Inc. now owns 1,019 shares of the company’s stock valued at $306,000 after purchasing an additional 143 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Cencora by 5.3% during the 2nd quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock worth $6,740,340,000 after purchasing an additional 1,125,661 shares in the last quarter. Finally, Empowered Funds LLC lifted its holdings in shares of Cencora by 10.6% during the 2nd quarter. Empowered Funds LLC now owns 20,128 shares of the company’s stock valued at $6,035,000 after buying an additional 1,922 shares during the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Leerink Partners restated an “outperform” rating on shares of Cencora in a report on Tuesday. Evercore reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Finally, Barclays raised their price objective on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Twelve investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Cencora has an average rating of “Moderate Buy” and a consensus target price of $403.17.

Cencora Price Performance

NYSE:COR opened at $325.50 on Thursday. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The stock has a market cap of $63.32 billion, a P/E ratio of 39.12, a PEG ratio of 1.56 and a beta of 0.68. The company has a fifty day moving average price of $355.15 and a 200 day moving average price of $339.41. Cencora, Inc. has a one year low of $262.73 and a one year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. During the same quarter in the prior year, the business earned $3.73 earnings per share. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. Analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were given a $0.60 dividend. The ex-dividend date was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s dividend payout ratio (DPR) is currently 28.85%.

Insider Transactions at Cencora

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of Cencora stock in a transaction on Friday, December 19th. The shares were sold at an average price of $345.00, for a total transaction of $578,565.00. Following the sale, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This represents a 7.10% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 10,124 shares of company stock valued at $3,532,646. 0.38% of the stock is owned by corporate insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.